Primary renal disease as a cardiovascular risk factor

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiovascular disease (CVD) is the primary cause of mortality in end-stage renal disease (ESRD) patients, occurring 3-5 times more frequently than in non-uremic individuals.
• Elevated CVD risk is observed even with mild to moderate renal dysfunction, especially in patients with hypertension or diabetes.
• Increased CVD risk is linked to modest elevations in serum creatinine and urinary albumin excretion in the general population, not just those with diabetes or hypertension.

Purpose of the Study:

• To highlight the significant link between renal dysfunction and cardiovascular disease risk.
• To emphasize the predictive value of renal disease screening in individuals with common cardiovascular risk factors.
• To discuss the therapeutic implications of targeting the kidney in managing hypertension, diabetes, and heart failure.

Main Methods:

• Review of recent studies and clinical observations linking renal function markers to cardiovascular outcomes.
• Analysis of epidemiological data on CVD mortality in ESRD patients.
• Examination of the role of the renin-angiotensin-aldosterone-kinin system in renal and cardiovascular protection.

Main Results:

• Cardiovascular disease is the predominant cause of death in ESRD.
• Mild to moderate renal dysfunction, indicated by serum creatinine and urinary albumin, is associated with increased CVD risk across populations.
• Interventions targeting the kidney can slow renal disease progression and reduce vascular complications.

Conclusions:

• Screening for renal disease is crucial for individuals with hypertension, diabetes, and other CVD risk factors.
• Identifying renal dysfunction aids in predicting high-risk patients for major cardiovascular events.
• Early detection and management of kidney disease are vital for mitigating cardiovascular mortality in at-risk populations.